Michael L. West

机构：Dalhousie University, EVERSANA (Canada) · ORCID：0000-0003-4897-1378

发表论文 307 篇 · 总被引 8282 次 · h-index 49

代表论文

• Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry (2022 · Orphanet Journal of Rare Diseases · 被引 74)
• Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data (2022 · The Lancet Infectious Diseases · 被引 52)
• Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study (2023 · Orphanet Journal of Rare Diseases · 被引 34)
• Renal and multisystem effectiveness of 3.9 years of migalastat in a global real‐world cohort: Results from the followME Fabry Pathfinders registry (2024 · Journal of Inherited Metabolic Disease · 被引 19)
• Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis (2023 · Kidney International · 被引 19)
• Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing (2023 · HIV Medicine · 被引 19)